Larimar Therapeutics Valuation
| LRMR Stock | USD 8.50 1.23 16.92% |
At this time, the firm appears to be undervalued. Larimar Therapeutics secures a last-minute Real Value of $9.92 per share. The latest price of the firm is $8.5. Our model forecasts the value of Larimar Therapeutics from analyzing the firm fundamentals such as Return On Equity of -0.27, current valuation of 248.91 M, and Shares Owned By Insiders of 1.45 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Larimar Therapeutics' valuation include:
Price Book 5.4338 | Enterprise Value 248.9 M | Enterprise Value Ebitda (8.75) |
Undervalued
Today
Please note that Larimar Therapeutics' price fluctuation is slightly risky at this time. Calculation of the real value of Larimar Therapeutics is based on 3 months time horizon. Increasing Larimar Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Larimar Therapeutics is useful when determining the fair value of the Larimar stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Larimar Therapeutics. Since Larimar Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Larimar Stock. However, Larimar Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.5 | Real 9.92 | Target 12.38 | Hype 8.3 |
The real value of Larimar Stock, also known as its intrinsic value, is the underlying worth of Larimar Therapeutics Company, which is reflected in its stock price. It is based on Larimar Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Larimar Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Larimar Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Larimar Therapeutics helps investors to forecast how Larimar stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Larimar Therapeutics more accurately as focusing exclusively on Larimar Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Larimar Therapeutics' intrinsic value based on its ongoing forecasts of Larimar Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Larimar Therapeutics' closest peers. When choosing an evaluation method for Larimar Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Larimar Therapeutics Investments |
|
Larimar Valuation Trend
Knowing Larimar Therapeutics' actual value is paramount for traders to make sound investment determinations. Larimar Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Larimar Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Larimar Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Larimar Market Cap
Larimar Therapeutics is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 20.76 Billion. Larimar Therapeutics holds roughly 470.86 Million in market capitalization claiming about 2.27% of equities under Health Care industry.Larimar Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Larimar Therapeutics's current stock value. Our valuation model uses many indicators to compare Larimar Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Larimar Therapeutics competition to find correlations between indicators driving Larimar Therapeutics's intrinsic value. More Info.Larimar Therapeutics is rated fourth overall in price to book category among related companies. It is rated below average in beta category among related companies totaling about 0.14 of Beta per Price To Book. The ratio of Price To Book to Beta for Larimar Therapeutics is roughly 7.01 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Larimar Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Larimar Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Larimar Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Larimar Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Larimar Therapeutics and how it compares across the competition.
About Larimar Therapeutics Valuation
The stock valuation mechanism determines the current worth of Larimar Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Larimar Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Larimar Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Larimar Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Larimar Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Larimar Therapeutics. We calculate exposure to Larimar Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Larimar Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -311 K | -326.6 K | |
| Pretax Profit Margin | 0.00 | 0.00 | |
| Operating Profit Margin | 0.00 | 0.00 | |
| Net Profit Margin | 0.00 | 0.00 | |
| Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct Larimar Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Larimar Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Larimar Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Larimar Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Larimar Therapeutics' revenue streams: Identify Larimar Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Larimar Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Larimar Therapeutics' growth potential: Evaluate Larimar Therapeutics' management, business model, and growth potential.
- Determine Larimar Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Larimar Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Larimar Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Larimar Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 43.9 M |
Larimar Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Larimar Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Larimar we look at many different elements of the entity such as Larimar's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Larimar Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Larimar Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Larimar Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Larimar Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Larimar Therapeutics' worth.When determining whether Larimar Therapeutics is a strong investment it is important to analyze Larimar Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Larimar Therapeutics' future performance. For an informed investment choice regarding Larimar Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Larimar Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Larimar Stock, please use our How to Invest in Larimar Therapeutics guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Larimar Stock analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Larimar Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Larimar Therapeutics. If investors know Larimar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Larimar Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Return On Assets (0.17) | Return On Equity (0.27) |
The market value of Larimar Therapeutics is measured differently than its book value, which is the value of Larimar that is recorded on the company's balance sheet. Investors also form their own opinion of Larimar Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Larimar Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Larimar Therapeutics' market value can be influenced by many factors that don't directly affect Larimar Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Larimar Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Larimar Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Larimar Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.